BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
ADvantage Therapeutics
/
Jeffrey Madden
JM
Jeffrey Madden
Co-Founder
ADvantage Therapeutics
Therapeutic Areas
Alzheimer's Disease
Neurodegenerative Diseases
ADvantage Therapeutics Pipeline
Drug
Indication
Phase
AD04™
Early Alzheimer's Disease
Phase 2
Leadership Team at ADvantage Therapeutics
FM
Frank Mattner
Co-Founder, Research Lead
WS
Walter Schmidt
Co-Founder
AS
Achim Schneeberger
Co-Founder
AF
Agustin Fernandez
Co-Founder
View full ADvantage Therapeutics profile